搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
4 天
FDA批准Niktimvo用于治疗慢性移植物抗宿主病
WILMINGTON, Del. 和 WALTHAM, Mass. - Incyte (NASDAQ:INCY) 和 Syndax Pharmaceuticals (NASDAQ:SNDX) 今天宣布,美国食品和药物管理局(FDA)最近批准了Niktimvo™(axatilimab-csfr)用于治疗体重至少40公斤的成人和儿童患者在两线系统治疗失败后的慢性移植物抗宿主病(GVHD)。这一宣布紧随 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Shooting suspect left note
Alabama mass shooting
Ga. suspect's mom indicted
Astronauts return to Earth
SpaceX plans Mars missions
1951 kidnap victim found
To meet Vietnamese pres
Daylight saving time
Robinson loses key staff
Visits US ammunition plant
Released after guilty plea
J&J unit files for bankruptcy
No govt. shutdown for now
Trump to campaign in MI
Tech ban proposed
California plastic bag ban
No. 1 at box office again
Dolphins legend Morris dies
Economic speech this week
Donlon's homes searched
Former WA governor dies
CA bill to protect kids online
CA firefighter held for arson
San Francisco homelessness
ISR raids Al Jazeera office
Free COVID-19 tests
PM Modi visits US
反馈